Evolving therapeutic landscape of diffuse large B-cell lymphoma: challenges and aspirations
Abstract Diffuse large B-cell lymphoma (DLBCL) represents the commonest subtype of non-Hodgkin lymphoma and encompasses a group of diverse disease entities, each harboring unique molecular and clinico-pathological features. The understanding of the molecular landscape of DLBCL has improved significa...
| Published in: | Discover Oncology |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
Springer
2023-07-01
|
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s12672-023-00754-8 |
